Zoledronate, fractures, and mortality after hip fracture [3]
Publication
, Journal Article
Karam, R; Al-Khalidi, H; Steinbuch, M
Published in: New England Journal of Medicine
February 28, 2008
Duke Scholars
Published In
New England Journal of Medicine
EISSN
1533-4406
ISSN
0028-4793
Publication Date
February 28, 2008
Volume
358
Issue
9
Start / End Page
968
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Karam, R., Al-Khalidi, H., & Steinbuch, M. (2008). Zoledronate, fractures, and mortality after hip fracture [3]. New England Journal of Medicine, 358(9), 968.
Karam, R., H. Al-Khalidi, and M. Steinbuch. “Zoledronate, fractures, and mortality after hip fracture [3].” New England Journal of Medicine 358, no. 9 (February 28, 2008): 968.
Karam R, Al-Khalidi H, Steinbuch M. Zoledronate, fractures, and mortality after hip fracture [3]. New England Journal of Medicine. 2008 Feb 28;358(9):968.
Karam, R., et al. “Zoledronate, fractures, and mortality after hip fracture [3].” New England Journal of Medicine, vol. 358, no. 9, Feb. 2008, p. 968.
Karam R, Al-Khalidi H, Steinbuch M. Zoledronate, fractures, and mortality after hip fracture [3]. New England Journal of Medicine. 2008 Feb 28;358(9):968.
Published In
New England Journal of Medicine
EISSN
1533-4406
ISSN
0028-4793
Publication Date
February 28, 2008
Volume
358
Issue
9
Start / End Page
968
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences